We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · September 20, 2022

MTIS 2022: Ongoing Study Evaluating Efficacy of Migraine Prevention in Patients With Depressionn

UNITE study examining efficacy and safety of fremanezumab with comorbid episodic or chronic migraine and major depressive disorder

PracticeUpdate Editorial Team


Further Reading